What is a stock summary page? Click here for an overview.
Business Description
ODI Pharma AB
ISIN : SE0013409760
Share Class Description:
XSAT:ODI: Ordinary SharesCompare
Compare
Traded in other countries / regions
ODI.Sweden6OD.Germany IPO Date
2020-01-23Description
ODI Pharma AB is a provider of medicinal cannabis. It offers its products to pharmacies, specialty clinics, and hospitals.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.07 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 5.2 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EPS without NRI Growth Rate | 57.5 | |||||
| 3-Year FCF Growth Rate | 14 | |||||
| 3-Year Book Growth Rate | -50.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 34.53 | |||||
| 9-Day RSI | 39.95 | |||||
| 14-Day RSI | 42.03 | |||||
| 3-1 Month Momentum % | -36.41 | |||||
| 6-1 Month Momentum % | -38.8 | |||||
| 12-1 Month Momentum % | -50.11 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.07 | |||||
| Quick Ratio | 1.07 | |||||
| Cash Ratio | 0.87 | |||||
| Days Inventory | 10.68 | |||||
| Days Sales Outstanding | 53.73 | |||||
| Days Payable | 60.38 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -6.39 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 20.32 | |||||
| Operating Margin % | -14.54 | |||||
| Net Margin % | -19.36 | |||||
| FCF Margin % | -18.22 | |||||
| ROE % | -245.06 | |||||
| ROA % | -43.62 | |||||
| ROIC % | -66.35 | |||||
| 3-Year ROIIC % | 152.2 | |||||
| ROC (Joel Greenblatt) % | -46378.79 | |||||
| ROCE % | -180.1 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.66 | |||||
| PB Ratio | 83.57 | |||||
| Price-to-Tangible-Book | 73.33 | |||||
| EV-to-EBIT | -9.69 | |||||
| EV-to-EBITDA | -9.69 | |||||
| EV-to-Revenue | 1.38 | |||||
| EV-to-FCF | -7.56 | |||||
| Price-to-GF-Value | 0.01 | |||||
| Price-to-Net-Current-Asset-Value | 73.33 | |||||
| Earnings Yield (Greenblatt) % | -10.32 | |||||
| FCF Yield % | -11.2 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ODI Pharma AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 21.51 | ||
| EPS (TTM) (kr) | -0.264 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 102.49 | ||
| 14-Day RSI | 42.03 | ||
| 14-Day ATR (kr) | 0.233079 | ||
| 20-Day SMA (kr) | 2.474 | ||
| 12-1 Month Momentum % | -50.11 | ||
| 52-Week Range (kr) | 2.02 - 8.134801 | ||
| Shares Outstanding (Mil) | 15.92 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ODI Pharma AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ODI Pharma AB Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
ODI Pharma AB Frequently Asked Questions
What is ODI Pharma AB(XSAT:ODI)'s stock price today?
The current price of XSAT:ODI is kr2.20. The 52 week high of XSAT:ODI is kr8.13 and 52 week low is kr2.02.
When is next earnings date of ODI Pharma AB(XSAT:ODI)?
The next earnings date of ODI Pharma AB(XSAT:ODI) is 2025-05-29.
Does ODI Pharma AB(XSAT:ODI) pay dividends? If so, how much?
ODI Pharma AB(XSAT:ODI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers